Govt. Exams
Entrance Exams
Elevated basal FSH (>10 IU/L on day 3) indicates reduced ovarian reserve, meaning fewer eggs remain in the ovaries, affecting fertility prognosis.
# Diagnosis of Vaginal Bleeding in Third Trimester with Previous Cesarean Deliveries
This clinical scenario involves a pregnant woman at 32 weeks gestation with vaginal bleeding and a significant obstetric history of three prior cesarean deliveries—key risk factors that guide differential diagnosis.
Step 1: Analyze the Clinical Presentation
Third trimester vaginal bleeding (after 20 weeks) narrows the differential to three main conditions:
- Placenta previa (painless bleeding)
- Placental abruption (painful bleeding with contractions)
- Placenta accreta/morbidly adherent placenta (usually asymptomatic until delivery)
The patient presents with vaginal bleeding without mention of abdominal pain or contractions, suggesting painless hemorrhage.
Step 2: Evaluate Risk Factors for Placenta Previa
Placenta previa risk increases with:
- Advanced maternal age (\(\geq 35\) years) ✓
- Multiple previous cesarean deliveries ✓
- Multiparity ✓
- Uterine scar tissue from prior procedures
This patient has multiple strong risk factors for placenta previa.
Step 3: Distinguish from Other Conditions
The absence of pain and the classic risk factors point away from abruption and accreta.
Step 4: Clinical Diagnosis
Placenta previa—where the placenta partially or completely covers the internal cervical os—is the most common cause of painless third-trimester bleeding and is strongly associated with maternal age, multiparity, and prior uterine surgery.
Answer: Placenta previa (Option B)
The combination of painless vaginal bleeding at 32 weeks, advanced maternal age (35 years), and three previous cesarean deliveries makes placenta previa the most likely diagnosis. Confirmation requires transvaginal ultrasound to visualize placental location.
Oocytes arrest in prophase I during fetal development and remain in this arrested state (dictyotene). First meiotic division completes just before ovulation, producing secondary oocyte and polar body.
Low testosterone with erectile dysfunction requires assessment of LH and FSH. If LH/FSH are low, it indicates secondary hypogonadism (pituitary/hypothalamic origin).
GnRH agonists cause initial stimulation followed by desensitization, suppressing endogenous LH and FSH to prevent premature ovulation during controlled ovarian hyperstimulation.
HSG is the first-line radiological investigation for assessing tubal patency and uterine cavity in suspected secondary infertility after normal male factor evaluation.
Elevated FSH with irregular cycles indicates diminished ovarian reserve characteristic of POI. PCOS typically shows normal or low FSH with hyperandrogenism.
Anticonvulsants like phenytoin induce hepatic metabolism of contraceptive hormones, reducing efficacy. Higher-dose estrogen pills or alternative methods are recommended.
The window of implantation occurs 6-10 days after ovulation (days 20-24 of a 28-day cycle) when the endometrium is optimally receptive for blastocyst implantation.
# STI Prevalence in India: Understanding HPV as the Most Common Infection
The most common sexually transmitted infection affecting reproductive health in India relates to viral pathogens with high transmission rates and significant public health burden. Let me analyze the comparative epidemiology of these infections.
## Step 1: Understand the Classification of STIs
STIs can be categorized as bacterial (Chlamydia, Gonorrhea, Syphilis) or viral (HPV). Viral STIs typically have:
- Higher prevalence rates in populations
- Persistent or chronic infection patterns
- Greater asymptomatic carrier rates
- Broader tissue tropism
## Step 2: Epidemiological Data on Bacterial STIs in India
According to recent epidemiological surveys:
- Syphilis: Declining trend with better screening programs
- Chlamydia trachomatis: Common but largely asymptomatic; estimated 2-5% prevalence in reproductive-age population
- Gonorrhea: Lower prevalence (~1-2%) compared to viral infections
## Step 3: HPV Prevalence and Public Health Impact
HPV demonstrates significantly higher prevalence:
- Affects approximately 25-30% of reproductive-age women in India
- Over 200 genotypes identified; high-risk types (16, 18) cause 99% of cervical cancers
- Most common viral STI globally and in India
- Asymptomatic transmission is common; many infections clear naturally
- Major burden on women's reproductive and cervical health
## Step 4: 2024 Data Context
Recent epidemiological studies and WHO reports (2023-2024) consistently identify HPV as the most prevalent STI affecting reproductive health in India, particularly due to its association with cervical cancer burden and need for widespread vaccination programs.
Answer: Human Papillomavirus (HPV) is the most common STI in India as per 2024 data, with significantly higher prevalence rates (25-30%) compared to bacterial STIs and major implications for cervical health and cancer prevention. (Option D)
